Navigation Links
Cliniqa Corporation Completes Asset Acquisition of Reagents Applications, Inc.
Date:10/29/2007

SAN MARCOS, Calif., Oct. 29 /PRNewswire/ -- Cliniqa Corporation (San Marcos, CA), a manufacturer of in-vitro diagnostic products, is pleased to announce the acquisition of the primary assets of Reagents Applications, Inc. "Raichem" (San Diego, CA), a wholly owned subsidiary of Hemagen Diagnostics, Inc. (Columbia, MD). Raichem is a manufacturer of clinical diagnostic products focusing on clinical chemistry reagents, calibrators, and controls. "The acquisition of Raichem and its comprehensive line of chemistry reagents, will allow CLINIQA to expand its liquid reagent offerings while adding lyophilization and dry powder manufacturing capabilities," states Granger Haugh, founder and Chief Executive Officer of Cliniqa Corporation.

"The acquisition of Raichem complements two previous acquisitions (Compass Bioscience and King Diagnostics, Inc.) completed within the last ninety days, and allows CLINIQA to offer an expanded portfolio of products and services to our customers. We can better leverage our liquid stabilization techniques and expertise within our technical organization," said Kevin Gould, President of Cliniqa Corporation.

About CLINIQA

CLINIQA, an ISO 13485:2003 certified company, is a manufacturer of reagents, calibrators, controls, and calibration verification products serving the in-vitro diagnostic industry. CLINIQA also supplies antisera, biochemicals, plasma, serum and contract manufacturing services for in-vitro diagnostic manufacturers. The company features proprietary True Liquid Control Technology in its products. CLINIQA is also the co-founder of "The Quality Alliance," formed to provide a range of innovative quality control products and an online Quality Analysis Peer Review application, InterQC, through common distribution channels in Europe, the U.S.A and Asia. Additional information may be found at http://www.cliniqa.com or contact the U.S. headquarters:

Tel: 1 800 728 5205 (within U.S.A)

+1 760 744 1900 (outside U.S.A)

Fax: +1 760-736-3773

E-mail: info@cliniqa.com


'/>"/>
SOURCE CLINIQA
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Trouble-shooting: Misincorporation or low fidelity
2. Roche Diagnostics Corporation
3. Roche Diagnostics Corporation
4. Promega Corporation: Wisconsins quiet innovator
5. Giuliani will keynote RedPrairie Corporations user conference
6. Madison Development Corporation makes loans to three area companies
7. Corporations and blogging
8. Metavante acquires Florida banking corporation
9. TriMas Corporations Cequent Group Acquires Chem-Chrome, Inc.
10. Sonic Foundry completes $11.25M stock offer
11. Orion Energy completes $5M capital round
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... , Febr. 10, 2016 /PRNewswire/ - BioAmber Inc. (NYSE: ... to announce that Mitsui & Co. Ltd., its partner ... acid plant, is investing an additional CDN$25 million in ... its stake from 30% to 40%.  Mitsui will also ... acid produced in Sarnia , providing ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... announced that it has joined the Human Vaccines Project, a public-private partnership ... and cancer. , The Human Vaccines Project brings together leading pharmaceutical ...
(Date:2/10/2016)... ... February 10, 2016 , ... HOLLOWAY AMERICA, ... Pharmaceutical Engineering (ISPE) Rocky Mountain Chapter 21st Annual Vendor Exhibition on Thursday, February ... than 100 tables for its annual event, which will run from 3:00 p.m. ...
(Date:2/10/2016)... ... February 10, 2016 , ... Global Stem ... agreement with Singapore-based Global Stem Cells Network (GSCN) and its affiliate Global ... in the latest adipose and bone marrow therapies. , Through the new ...
Breaking Biology Technology:
(Date:2/9/2016)... Mass., Feb. 9, 2016 Aware, Inc. (NASDAQ: AWRE ... financial results for its fourth quarter and year ended December 31, ... for the fourth quarter of 2015 was $6.9 million, an increase ... year. Operating income in the fourth quarter of 2015 was $2.6 ... --> --> Higher revenue ...
(Date:2/3/2016)... GOTHENBURG, Sweden , February 4, 2016 ... Revenues amounted to SEK 1,351.5 M (105.0), up 1,187% compared with fourth ... Operating profit amounted to SEK 517.6 M (loss: 30.0). Earnings ... from operating activities was SEK 537.4 M (neg: 74.7). , ... , Revenues amounted to SEK 2,900.5 M (233.6), up 1,142% ...
(Date:2/2/2016)... Feb. 2, 2016 This BCC Research ... market by reviewing the recent advances in high ... drive the field forward. Includes forecast through 2019. ... the challenges and opportunities that exist in the ... solution developers, as well as IT and bioinformatics ...
Breaking Biology News(10 mins):